Anti-NCOA4 antibody [EPR28511-12] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal NCOA4 antibody. Carrier free. Suitable for WB, IP and reacts with Human, Mouse, Rat samples.
View Alternative Names
ARA70, ELE1, RFG, NCOA4, Nuclear receptor coactivator 4, NCoA-4, Androgen receptor coactivator 70 kDa protein, Androgen receptor-associated protein of 70 kDa, Ferritin cargo receptor NCOA4, Ret-activating protein ELE1, 70 kDa AR-activator, 70 kDa androgen receptor coactivator
- IP
Supplier Data
Immunoprecipitation - Anti-NCOA4 antibody [EPR28511-12] - BSA and Azide free (AB314554)
This data was developed using ab314553, the same antibody clone in a different buffer formulation. NCOA4 was immunoprecipitated from 0.35 mg HepG2 (human hepatocellular carcinoma epithelial cell) whole cell lysate with ab314553 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab314553 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution. Lane 1 : HepG2 (human hepatocellular carcinoma epithelial cell) whole cell lysate Lane 2 : ab314553 IP in HepG2 (human hepatocellular carcinoma epithelial cell) whole cell lysate Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab314553 in HepG2 whole cell lysate Blocking and dilution buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-NCOA4 antibody [EPR28511-12] (<a href='/en-us/products/primary-antibodies/ncoa4-antibody-epr28511-12-ab314553'>ab314553</a>) at 1/30 dilution
All lanes:
HepG2 (human hepatocellular carcinoma epithelial cell) whole cell lysate
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
false
Exposure time: 32s
- IP
Supplier Data
Immunoprecipitation - Anti-NCOA4 antibody [EPR28511-12] - BSA and Azide free (AB314554)
This data was developed using ab314553, the same antibody clone in a different buffer formulation. NCOA4 was immunoprecipitated from 0.35 mg NIH/3T3 (mouse embryonic fibroblast) whole cell lysate with ab314553 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab314553 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution. Lane 1 : NIH/3T3 (mouse embryonic fibroblast) whole cell lysate Lane 2 : ab314553 IP in NIH/3T3 (mouse embryonic fibroblast) whole cell lysate Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab314553 in NIH/3T3 whole cell lysate Blocking and dilution buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-NCOA4 antibody [EPR28511-12] (<a href='/en-us/products/primary-antibodies/ncoa4-antibody-epr28511-12-ab314553'>ab314553</a>) at 1/30 dilution
All lanes:
NIH/3T3 (mouse embryonic fibroblast) whole cell lysate
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
false
Exposure time: 32s
- WB
Supplier Data
Western blot - Anti-NCOA4 antibody [EPR28511-12] - BSA and Azide free (AB314554)
This data was developed using ab314553, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 24695223, 31061094).
Lysates were freshly made and used for Western blotting immediately to minimize protein degradation.
All lanes:
Western blot - Anti-NCOA4 antibody [EPR28511-12] (<a href='/en-us/products/primary-antibodies/ncoa4-antibody-epr28511-12-ab314553'>ab314553</a>) at 1/1000 dilution
Lane 1:
PC-3 (human prostate adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 3:
293T (human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Lane 4:
NIH/3T3 (mouse embryonic fibroblast) whole cell lysate at 20 µg
Lane 5:
PC-12 (rat adrenal gland pheochromocytoma) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 75 kDa,76 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-NCOA4 antibody [EPR28511-12] - BSA and Azide free (AB314554)
This data was developed using ab314553, the same antibody clone in a different buffer formulation. Blocking and diluting buffer and concentration : 5% NFDM/TBST The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 24695223, 31061094). The lysates of lanes 2-3 were freshly made and used for Western blotting immediately to minimize protein degradation. In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
All lanes:
Western blot - Anti-NCOA4 antibody [EPR28511-12] (<a href='/en-us/products/primary-antibodies/ncoa4-antibody-epr28511-12-ab314553'>ab314553</a>) at 1/1000 dilution
Lane 1:
Human testis tissue lysate at 20 µg
Lane 2:
Mouse testis tissue lysate at 20 µg
Lane 3:
Rat testis tissue lysate at 20 µg
Secondary
Lanes 1 - 3:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Lanes 1 - 3:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Observed band size: 75 kDa,76 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-NCOA4 antibody [EPR28511-12] - BSA and Azide free (AB314554)
This data was developed using ab314553, the same antibody clone in a different buffer formulation. Blocking and diluting buffer and concentration : 5% NFDM/TBST The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 24695223, 31061094). Lysates were freshly made and used for Western blotting immediately to minimize protein degradation. In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
All lanes:
Western blot - Anti-NCOA4 antibody [EPR28511-12] (<a href='/en-us/products/primary-antibodies/ncoa4-antibody-epr28511-12-ab314553'>ab314553</a>) at 1/1000 dilution
Lane 1:
HepG2 (human hepatocellar carcinoma epithelial cell) transfected with scrambled siRNA control whole cell lysate at 20 µg
Lane 2:
HepG2 transfected with siRNA specifically targeti NCOA4 whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 75 kDa,76 kDa
false
Exposure time: 147s
- WB
Supplier Data
Western blot - Anti-NCOA4 antibody [EPR28511-12] - BSA and Azide free (AB314554)
This data was developed using ab314553, the same antibody clone in a different buffer formulation. Blocking and diluting buffer and concentration : 5% NFDM/TBST Low expression : HT-1080. The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 24695223, 31061094). In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
All lanes:
Western blot - Anti-NCOA4 antibody [EPR28511-12] (<a href='/en-us/products/primary-antibodies/ncoa4-antibody-epr28511-12-ab314553'>ab314553</a>) at 1/1000 dilution
Lane 1:
MEF (mouse embryonic fibroblast (immortalized)) whole cell lysate at 20 µg
Lane 2:
A-172 (human brain glioblastoma) whole cell lysate at 20 µg
Lane 3:
HT-1080 (human fibrosarcoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 75 kDa,76 kDa
false
Exposure time: 180s
Related conjugates and formulations (1)
-
Anti-NCOA4 antibody [EPR28511-12]
Reactivity data
Product details
ab314554 is the carrier-free version of ab314553.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
NCOA4 modulates cellular iron homeostasis which is essential for cell survival and proliferation. It accomplishes this by mediating the autophagic degradation of ferritin a protein that stores iron through ferritinophagy. As part of the ferritinophagy complex NCOA4 works alongside other autophagic machinery to regulate iron bioavailability and mitigate oxidative stress maintaining cellular health and function.
Pathways
NCOA4 significantly influences the iron metabolism pathway an important component in maintaining iron balance within cells. The interaction with proteins such as ferritin highlights its role in facilitating iron release and utilization. Furthermore NCOA4 intersects with the autophagy pathway where it coordinates with autophagic proteins like LC3 to ensure proper iron recycling emphasizing its integration in cellular nutrient management.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com